$2.97 Billion is the total value of Ikarian Capital, LLC's 292 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARKK | New | ARK ETF TRput | $131,945,000 | – | 1,100,000 | +100.0% | 4.44% | – |
| IWM | New | ISHARES TRput | $99,422,000 | – | 450,000 | +100.0% | 3.35% | – |
| QQQ | New | INVESCO QQQ TRput | $63,826,000 | – | 200,000 | +100.0% | 2.15% | – |
| TLT | New | ISHARES TRcall | $54,180,000 | – | 400,000 | +100.0% | 1.82% | – |
| XLI | New | SELECT SECTOR SPDR TRcall | $49,226,000 | – | 500,000 | +100.0% | 1.66% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INCput | $42,977,000 | – | 200,000 | +100.0% | 1.45% | – |
| SOXX | New | ISHARES TRput | $42,398,000 | – | 100,000 | +100.0% | 1.43% | – |
| TLT | New | ISHARES TRput | $40,635,000 | – | 300,000 | +100.0% | 1.37% | – |
| XLF | New | SELECT SECTOR SPDR TRcall | $37,773,000 | – | 1,109,400 | +100.0% | 1.27% | – |
| IBB | New | ISHARES TRcall | $37,640,000 | – | 250,000 | +100.0% | 1.27% | – |
| MRTX | New | MIRATI THERAPEUTICS INCput | $27,751,000 | – | 162,000 | +100.0% | 0.93% | – |
| EXAS | New | EXACT SCIENCES CORPput | $27,015,000 | – | 205,000 | +100.0% | 0.91% | – |
| BHC | New | BAUSCH HEALTH COS INCcall | $25,392,000 | – | 800,000 | +100.0% | 0.86% | – |
| SMH | New | VANECK VECTORS ETF TRput | $24,354,000 | – | 100,000 | +100.0% | 0.82% | – |
| LLY | New | LILLY ELI & CO | $23,352,000 | – | 125,000 | +100.0% | 0.79% | – |
| SAGE | New | SAGE THERAPEUTICS INCput | $18,713,000 | – | 250,000 | +100.0% | 0.63% | – |
| JAZZ | New | JAZZ PHARMACEUTICALS PLCcall | $16,437,000 | – | 100,000 | +100.0% | 0.55% | – |
| INCY | New | INCYTE CORPcall | $16,254,000 | – | 200,000 | +100.0% | 0.55% | – |
| MGNX | New | MACROGENICS INC | $15,940,000 | – | 500,469 | +100.0% | 0.54% | – |
| GLPG | New | GALAPAGOS NVspon adr | $15,513,000 | – | 200,000 | +100.0% | 0.52% | – |
| BA | New | BOEING COcall | $15,283,000 | – | 60,000 | +100.0% | 0.51% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INCput | $14,921,000 | – | 578,300 | +100.0% | 0.50% | – |
| TWST | New | TWIST BIOSCIENCE CORPput | $14,864,000 | – | 120,000 | +100.0% | 0.50% | – |
| MRNA | New | MODERNA INCcall | $13,094,000 | – | 100,000 | +100.0% | 0.44% | – |
| XLU | New | SELECT SECTOR SPDR TRcall | $12,809,000 | – | 200,000 | +100.0% | 0.43% | – |
| NVAX | New | NOVAVAX INCcall | $12,693,000 | – | 70,000 | +100.0% | 0.43% | – |
| TXG | New | 10X GENOMICS INCput | $12,669,000 | – | 70,000 | +100.0% | 0.43% | – |
| CCXI | New | CHEMOCENTRYX INCcall | $10,248,000 | – | 200,000 | +100.0% | 0.34% | – |
| RLMD | New | RELMADA THERAPEUTICS INC | $10,218,000 | – | 290,207 | +100.0% | 0.34% | – |
| GMTX | New | GEMINI THERAPEUTICS INC | $9,273,000 | – | 684,379 | +100.0% | 0.31% | – |
| CVAC | New | CUREVAC N Vcall | $9,145,000 | – | 100,000 | +100.0% | 0.31% | – |
| EPIX | New | ESSA PHARMA INC | $7,694,000 | – | 264,868 | +100.0% | 0.26% | – |
| GLPG | New | GALAPAGOS NVcall | $7,709,000 | – | 100,000 | +100.0% | 0.26% | – |
| SDGR | New | SCHRODINGER INCput | $7,628,000 | – | 100,000 | +100.0% | 0.26% | – |
| NVTA | New | INVITAE CORPput | $7,642,000 | – | 200,000 | +100.0% | 0.26% | – |
| ARGX | New | ARGENX SEcall | $7,407,000 | – | 26,900 | +100.0% | 0.25% | – |
| ADCT | New | ADC THERAPEUTICS SAcall | $7,323,000 | – | 300,000 | +100.0% | 0.25% | – |
| MCRB | New | SERES THERAPEUTICS INC | $7,206,000 | – | 350,000 | +100.0% | 0.24% | – |
| AUTL | New | AUTOLUS THERAPEUTICS PLCspon ads | $7,196,000 | – | 1,256,048 | +100.0% | 0.24% | – |
| RLMD | New | RELMADA THERAPEUTICS INCcall | $6,958,000 | – | 197,600 | +100.0% | 0.23% | – |
| RVMD | New | REVOLUTION MEDICINES INCcall | $6,882,000 | – | 150,000 | +100.0% | 0.23% | – |
| MGNX | New | MACROGENICS INCcall | $6,371,000 | – | 200,000 | +100.0% | 0.21% | – |
| MSOS | New | ADVISORSHARES TRcall | $6,360,000 | – | 150,000 | +100.0% | 0.21% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INCput | $6,332,000 | – | 200,000 | +100.0% | 0.21% | – |
| LRMR | New | LARIMAR THERAPEUTICS INC | $6,215,000 | – | 425,384 | +100.0% | 0.21% | – |
| IMVT | New | IMMUNOVANT INCcall | $5,802,000 | – | 361,700 | +100.0% | 0.20% | – |
| HARP | New | HARPOON THERAPEUTICS INC | $5,619,000 | – | 268,600 | +100.0% | 0.19% | – |
| ANVS | New | ANNOVIS BIO INC | $5,395,000 | – | 193,368 | +100.0% | 0.18% | – |
| SYBX | New | SYNLOGIC INC | $5,343,000 | – | 1,492,614 | +100.0% | 0.18% | – |
| ALVR | New | ALLOVIR INCcall | $4,680,000 | – | 200,000 | +100.0% | 0.16% | – |
| VKTX | New | VIKING THERAPEUTICS INC | $4,584,000 | – | 724,754 | +100.0% | 0.15% | – |
| ODT | New | ODONATE THERAPEUTICS INC | $4,571,000 | – | 1,336,412 | +100.0% | 0.15% | – |
| STRO | New | SUTRO BIOPHARMA INCcall | $4,553,000 | – | 200,000 | +100.0% | 0.15% | – |
| OVID | New | OVID THERAPEUTICS INC | $4,522,000 | – | 1,124,872 | +100.0% | 0.15% | – |
| ALLK | New | ALLAKOS INCput | $4,327,000 | – | 37,700 | +100.0% | 0.15% | – |
| CABA | New | CABALETTA BIO INC | $4,323,000 | – | 389,384 | +100.0% | 0.14% | – |
| PLRX | New | PLIANT THERAPEUTICS INC | $4,275,000 | – | 108,700 | +100.0% | 0.14% | – |
| ALLO | New | ALLOGENE THERAPEUTICS INCcall | $4,115,000 | – | 116,600 | +100.0% | 0.14% | – |
| ALRN | New | AILERON THERAPEUTICS INC | $4,004,000 | – | 2,800,000 | +100.0% | 0.14% | – |
| STSA | New | SATSUMA PHARMACEUTICALS INC | $3,997,000 | – | 676,294 | +100.0% | 0.14% | – |
| STOK | New | STOKE THERAPEUTICS INCput | $3,962,000 | – | 102,000 | +100.0% | 0.13% | – |
| IMVT | New | IMMUNOVANT INCput | $3,895,000 | – | 242,800 | +100.0% | 0.13% | – |
| BGNE | New | BEIGENE LTDcall | $3,655,000 | – | 10,500 | +100.0% | 0.12% | – |
| ALLK | New | ALLAKOS INC | $3,639,000 | – | 31,700 | +100.0% | 0.12% | – |
| SEEL | New | SEELOS THERAPEUTICS INC | $3,585,000 | – | 718,284 | +100.0% | 0.12% | – |
| BCAB | New | BIOATLA INC | $3,567,000 | – | 70,160 | +100.0% | 0.12% | – |
| SVRA | New | SAVARA INC | $3,566,000 | – | 1,714,366 | +100.0% | 0.12% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $3,373,000 | – | 341,500 | +100.0% | 0.11% | – |
| MRSN | New | MERSANA THERAPEUTICS INCcall | $3,237,000 | – | 200,000 | +100.0% | 0.11% | – |
| CAPA | New | HIGHCAPE CAP ACQUISITION COR | $3,099,000 | – | 260,000 | +100.0% | 0.10% | – |
| CBIO | New | CATALYST BIOSCIENCES INC | $2,929,000 | – | 581,200 | +100.0% | 0.10% | – |
| ELDN | New | ELEDON PHARMACEUTICALS INC | $2,676,000 | – | 250,000 | +100.0% | 0.09% | – |
| XENE | New | XENON PHARMACEUTICALS INCcall | $2,687,000 | – | 150,100 | +100.0% | 0.09% | – |
| NUVB | New | NUVATION BIO INC | $2,613,000 | – | 250,000 | +100.0% | 0.09% | – |
| FNCH | New | FINCH THERAPEUTICS GROUP INC | $2,387,000 | – | 150,000 | +100.0% | 0.08% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS INcall | $2,308,000 | – | 100,000 | +100.0% | 0.08% | – |
| ZLAB | New | ZAI LAB LTDadr | $2,249,000 | – | 17,000 | +100.0% | 0.08% | – |
| HSAQ | New | HEALTH SCIENCES ACQ CORP 2 | $2,246,000 | – | 200,000 | +100.0% | 0.08% | – |
| RARE | New | ULTRAGENYX PHARMACEUTICAL INput | $2,094,000 | – | 18,400 | +100.0% | 0.07% | – |
| RGLS | New | REGULUS THERAPEUTICS INC | $1,943,000 | – | 1,245,989 | +100.0% | 0.06% | – |
| CLOV | New | CLOVER HEALTH INVESTMENTS COcall | $1,890,000 | – | 250,000 | +100.0% | 0.06% | – |
| FREQ | New | FREQUENCY THERAPEUTICS INCcall | $1,900,000 | – | 200,000 | +100.0% | 0.06% | – |
| INCY | New | INCYTE CORP | $1,870,000 | – | 23,012 | +100.0% | 0.06% | – |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $1,838,000 | – | 15,084 | +100.0% | 0.06% | – |
| ORTX | New | ORCHARD THERAPEUTICS PLCads | $1,815,000 | – | 250,000 | +100.0% | 0.06% | – |
| PDSB | New | PDS BIOTECHNOLOGY CORP | $1,745,000 | – | 383,373 | +100.0% | 0.06% | – |
| CVM | New | CEL-SCI CORPcall | $1,627,000 | – | 106,900 | +100.0% | 0.06% | – |
| VBLT | New | VASCULAR BIOGENICS LTD | $1,601,000 | – | 800,811 | +100.0% | 0.05% | – |
| EARS | New | AURIS MEDICAL HOLDING LTD | $1,605,000 | – | 461,522 | +100.0% | 0.05% | – |
| CLNN | New | CLENE INC | $1,516,000 | – | 118,533 | +100.0% | 0.05% | – |
| IPA | New | IMMUNOPRECISE ANTIBODIES LTD | $1,472,000 | – | 150,000 | +100.0% | 0.05% | – |
| CMRX | New | CHIMERIX INCcall | $1,446,000 | – | 150,000 | +100.0% | 0.05% | – |
| VIRX | New | VIRACTA THERAPEUTICS INC | $1,439,000 | – | 155,599 | +100.0% | 0.05% | – |
| SRRK | New | SCHOLAR ROCK HLDG CORPcall | $1,433,000 | – | 28,300 | +100.0% | 0.05% | – |
| WVE | New | WAVE LIFE SCIENCES LTDcall | $1,403,000 | – | 250,000 | +100.0% | 0.05% | – |
| PBLA | New | PANBELA THERAPEUTICS INC | $1,363,000 | – | 345,013 | +100.0% | 0.05% | – |
| SRNE | New | SORRENTO THERAPEUTICS INC | $1,372,000 | – | 165,900 | +100.0% | 0.05% | – |
| RUBY | New | RUBIUS THERAPEUTICS INC | $1,326,000 | – | 50,000 | +100.0% | 0.04% | – |
| EYPT | New | EYEPOINT PHARMACEUTICALS INC | $1,221,000 | – | 120,135 | +100.0% | 0.04% | – |
| TDOC | New | TELADOC HEALTH INCput | $1,181,000 | – | 6,500 | +100.0% | 0.04% | – |
| ONTX | New | ONCONOVA THERAPEUTICS INC | $1,144,000 | – | 1,145,426 | +100.0% | 0.04% | – |
| BCLI | New | BRAINSTORM CELL THERAPEUTICS | $1,122,000 | – | 293,200 | +100.0% | 0.04% | – |
| ACIU | New | AC IMMUNE SA | $911,000 | – | 119,803 | +100.0% | 0.03% | – |
| CYCN | New | CYCLERION THERAPEUTICS INC | $836,000 | – | 300,000 | +100.0% | 0.03% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $808,000 | – | 35,000 | +100.0% | 0.03% | – |
| FLACU | New | FRAZIER LIFESCIENCES ACQU COunit 12/09/2025 | $766,000 | – | 75,000 | +100.0% | 0.03% | – |
| CLOV | New | CLOVER HEALTH INVESTMENTS CO | $757,000 | – | 100,000 | +100.0% | 0.02% | – |
| OCUP | New | OCUPHIRE PHARMA INC | $693,000 | – | 119,551 | +100.0% | 0.02% | – |
| VLON | New | VALLON PHARMACEUTICALS INC | $649,000 | – | 140,000 | +100.0% | 0.02% | – |
| FREQ | New | FREQUENCY THERAPEUTICS INC | $536,000 | – | 56,479 | +100.0% | 0.02% | – |
| VCEL | New | VERICEL CORPcall | $439,000 | – | 7,900 | +100.0% | 0.02% | – |
| SLS | New | SELLAS LIFE SCIENCES GROUP I | $410,000 | – | 48,053 | +100.0% | 0.01% | – |
| FATE | New | FATE THERAPEUTICS INC | $297,000 | – | 3,600 | +100.0% | 0.01% | – |
| CHAQ | New | CHARDAN HEALTHCR ACQSTN 2 CO | $301,000 | – | 30,000 | +100.0% | 0.01% | – |
| CRVS | New | CORVUS PHARMACEUTICALS INC | $307,000 | – | 100,000 | +100.0% | 0.01% | – |
| BTAI | New | BIOXCEL THERAPEUTICS INC | $226,000 | – | 5,232 | +100.0% | 0.01% | – |
| GNCA | New | GENOCEA BIOSCIENCES INC | $213,000 | – | 78,767 | +100.0% | 0.01% | – |
| ARKG | New | ARK ETF TRgenomic rev etf | $178,000 | – | 2,000 | +100.0% | 0.01% | – |
| ARNA | New | ARENA PHARMACEUTICALS INC | $153,000 | – | 2,200 | +100.0% | 0.01% | – |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $60,000 | – | 600 | +100.0% | 0.00% | – |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $56,000 | – | 603 | +100.0% | 0.00% | – |
| LEGN | New | LEGEND BIOTECH CORPput | $44,000 | – | 1,500 | +100.0% | 0.00% | – |
| CGEM | New | CULLINAN ONCOLOGY INC | $42,000 | – | 1,000 | +100.0% | 0.00% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $10,000 | – | 134 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-08-18
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 15 | Q2 2023 | 1.5% |
| OCULAR THERAPEUTIX INC | 15 | Q3 2023 | 1.4% |
| SAREPTA THERAPEUTICS INC | 14 | Q3 2023 | 6.4% |
| X4 PHARMACEUTICALS INC - PIPE | 14 | Q2 2023 | 1.4% |
| PROTARA THERAPEUTICS INC | 14 | Q3 2023 | 1.2% |
| SPDR SER TR | 13 | Q3 2023 | 9.0% |
| VAXCYTE INC | 13 | Q3 2023 | 2.9% |
| TRACON PHARMACEUTICALS INC | 13 | Q3 2023 | 1.4% |
| MILESTONE PHARMACEUTICALS IN | 13 | Q3 2023 | 1.7% |
| BELLUS HEALTH INC NEW | 13 | Q1 2023 | 1.8% |
View Ikarian Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 460,416 | 1.3% |
| X4 Pharmaceuticals, Inc | February 14, 2023 | 349,133 | 0.3% |
| aTYR PHARMA INC | February 14, 2022 | 35,048 | 0.1% |
| Cyclacel Pharmaceuticals, Inc. | February 14, 2022 | 99,422 | 1.0% |
| KalVista Pharmaceuticals, Inc. | February 14, 2022 | 36,576 | 0.2% |
| Lyra Therapeutics, Inc. | February 14, 2022 | 394,536 | 3.0% |
| Odonate Therapeutics, Inc. | February 14, 2022 | 1,340,631 | 3.5% |
| Protara Therapeutics, Inc. | February 14, 2022 | 279,256 | 2.5% |
| Science 37 Holdings, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| scPharmaceuticals Inc. | February 14, 2022 | 901,362 | 3.3% |
View Ikarian Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View Ikarian Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.